Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure

This publication has 19 references indexed in Scilit:

• Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer
  Lung Cancer, 2003
• Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2003
• Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial ct scan-based study
  International Journal of Radiation Oncology*Biology*Physics, 2001
• F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma
  Cancer, 2001
• Combined modality treatment using concurrent radiotherapy and pharmacologically-guided carboplatin for inoperable and incompletely resected non-small cell lung cancer
  Lung Cancer, 2001
• Radiation effects on the lung: clinical features, pathology, and imaging findings.
  American Journal of Roentgenology, 1992
• Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
  Investigational New Drugs, 1992
• Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.
  Radiology, 1992
• The New International Staging System for Lung Cancer
  Surgical Clinics of North America, 1987
• Radiation fibrosis mimicking local recurrence in small cell carcinoma of the bronchus
  The British Journal of Radiology, 1984